Pretreatment Metabolic Score Stratifies Risk in Non-Metastatic Nasopharyngeal Carcinoma
A retrospective study of 160 patients evaluated an integrated metabolic vulnerability score to stratify progression-free survival in non-metastatic nasopharyngeal carcinoma.

